BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 134121)

  • 1. Human transfer factor: fractionation and biologic activity.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):789-96. PubMed ID: 134121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human transfer factor: effects on lymphocyte transformation.
    Burger DR; Vandenbark AA; Finke P; Nolte JE; Vetto RM
    J Immunol; 1976 Sep; 117(3):782-8. PubMed ID: 956653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor.
    Burger DR; Vandenbark AA; Daves D; Anderson WA; Vetto RM; Finke P
    J Immunol; 1976 Sep; 117(3):797-801. PubMed ID: 134122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human transfer factor: fractionation by electrofocusing and high pressure, reverse phase chromatography.
    Vandenbark AA; Burger DR; Dreyer DL; Daves GD; Vetto RM
    J Immunol; 1977 Feb; 118(2):636-41. PubMed ID: 839073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity.
    Krohn K; Gröhn P; Horsmanheimo M; Virolainen M
    Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation.
    Salaman MR
    Immunology; 1978 Aug; 35(2):247-56. PubMed ID: 86502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities.
    Burger DR; Vandenbark AA; Dunnick W; Kraybill W; Daves GD; Vetto RM
    J Immunol; 1979 Mar; 122(3):1091-8. PubMed ID: 448071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
    Wilson GB; Fudenberg HH
    J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of transfer factor. In vitro lymphoblast transformation of peripheral lymphocytes to Leishmania major antigen in the presence of transfer factor.
    Sharma MK; Anaraki F; Ala F
    Scand J Immunol; 1977; 6(11):1101-6. PubMed ID: 74087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity of human seminal plasma. I. Inhibition of in vitro lymphocyte activation.
    Lord EM; Sensabaugh GF; Stites DP
    J Immunol; 1977 May; 118(5):1704-11. PubMed ID: 140192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine.
    Ashorn RG; Räsänen L; Marnela KM; Krohn KJ
    Clin Exp Immunol; 1979 Jul; 37(1):50-7. PubMed ID: 385187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?
    Sargent IL; Salaman MR
    Immunology; 1980 Sep; 41(1):227-35. PubMed ID: 6159314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfer of delayed type hypersensitivity in guinea pigs].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.
    Nékám K; Kalmár L; Gergely P; Kelemen G; Fekete B; Láng I; Lévai J; Petrányi GY
    Clin Exp Immunol; 1977 Mar; 27(3):416-20. PubMed ID: 324669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory properties of fractions from human pregnancy urine: evidence that human chorionic gonadotropin is not responsible.
    Muchmore AV; Blaese RM
    J Immunol; 1977 Mar; 118(3):881-6. PubMed ID: 139448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells.
    Novogrodsky A; Stenzel KH; Rubin AL
    J Immunol; 1977 Mar; 118(3):852-7. PubMed ID: 191527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The adjuvant and specific activity of transfer factors to Candida albicans antigens].
    Borysov VA; Cheusova ZV; Molozhava OS
    Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of monocytes in human lymphocyte activation by mitogens.
    de Vries JE; Caviles AP; Bont WS; Mendelsohn J
    J Immunol; 1979 Mar; 122(3):1099-107. PubMed ID: 448072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.